Cellectis SA (CLLS)
1.41
-0.10
(-6.62%)
USD |
NASDAQ |
Dec 27, 16:00
1.43
+0.02
(+1.42%)
After-Hours: 20:00
Cellectis Cash from Investing (Quarterly): 22.33M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Edap TMS SA | -1.120M |
| DBV Technologies SA | -0.109M |
| Genfit SA | -- |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.829M |
| Cash from Financing (Quarterly) | -4.218M |
| Free Cash Flow | 60.38M |
| Free Cash Flow Per Share (Quarterly) | -0.0663 |
| Free Cash Flow to Equity (Quarterly) | -8.455M |
| Free Cash Flow to Firm (Quarterly) | -6.634M |
| Free Cash Flow Yield | 47.79% |